Oracle (ORCL) Financials

$162.92 -0.93 (-0.57%)

Closing price 03:59 PM Eastern

Extended Trading

$162.07 -0.85 (-0.52%)

As of 07:58 PM Eastern

Annual Income Statements for Oracle

This table shows Oracle's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015
Net Income / (Loss) Attributable to Common Shareholders	10,467	8,503	6,717	13,746	10,135	11,083	3,587	9,452	8,901	9,938
Consolidated Net Income / (Loss)	10,467	8,503	6,717	13,746	10,135	11,083	3,587	9,452	8,901	9,938
Net Income / (Loss) Continuing Operations	10,467	8,503	6,717	13,746	10,135	11,083	3,587	9,452	8,901	9,938
Total Pre-Tax Income	11,741	9,126	7,649	12,999	12,063	12,268	12,424	11,680	11,442	12,834
Total Operating Income	15,353	13,093	10,926	15,213	13,896	13,535	13,264	12,913	12,604	13,871
Total Gross Profit	42,643	41,151	36,255	35,154	33,946	34,364	31,323	30,340	29,568	30,694
Total Revenue	52,961	49,954	42,440	40,479	39,068	39,506	39,383	37,792	37,047	38,226
Operating Revenue	52,961	49,954	42,440	40,479	39,068	39,506	39,383	37,792	37,047	38,226
Total Cost of Revenue	10,318	8,803	6,185	5,325	5,122	5,142	8,060	7,452	7,479	7,532
Operating Cost of Revenue	10,318	8,803	6,185	5,325	5,122	5,142	8,060	7,452	7,479	7,532
Total Operating Expenses	27,290	28,058	25,329	19,941	20,050	20,829	18,059	17,427	16,964	16,823
Selling, General & Admin Expense	1,548	1,579	1,317	1,254	1,181	1,265	1,282	1,172	1,155	1,077
Marketing Expense	8,274	8,833	8,047	7,682	8,094	8,509	8,433	8,085	7,884	7,655
Research & Development Expense	8,915	8,623	7,219	6,527	6,067	6,026	6,084	6,153	5,787	5,524
Amortization Expense	3,010	3,582	1,150	1,379	1,586	1,689	1,620	1,451	1,638	2,149
Other Operating Expenses / (Income)	4,825	4,761	2,692	2,530	2,816	2,853	-	-	-	-
Restructuring Charge	718	680	4,904	569	306	487	640	566	500	418
Total Other Income / (Expense), net	-3,612	-3,967	-3,277	-2,214	-1,833	-1,267	-840	-1,233	-1,162	-1,037
Interest Expense	3,514	3,505	2,755	2,496	1,995	2,082	2,025	1,798	1,467	1,143
Other Income / (Expense), net	-98	-462	-522	282	162	815	1,185	565	305	106
Income Tax Expense	1,274	623	932	-747	1,928	1,185	8,837	2,228	2,541	2,896
Basic Earnings per Share	$3.82	$3.15	$2.49	$4.67	$3.16	$3.05	$0.87	$2.30	$2.11	$2.26
Weighted Average Basic Shares Outstanding	2.74B	2.70B	2.70B	2.95B	3.21B	3.63B	4.12B	4.12B	4.22B	4.40B
Diluted Earnings per Share	$3.71	$3.07	$2.41	$4.55	$3.08	$2.97	$0.85	$2.24	$2.07	$2.21
Weighted Average Diluted Shares Outstanding	2.82B	2.77B	2.79B	3.02B	3.29B	3.73B	4.24B	4.22B	4.31B	4.50B
Weighted Average Basic & Diluted Shares Outstanding	2.76B	2.71B	2.66B	2.79B	3.07B	3.63B	4.12B	4.11B	4.12B	4.34B
Cash Dividends to Common per Share	$1.60	$1.36	$1.28	$1.04	$0.96	$0.81	$0.76	$0.64	$0.60	$0.51

This table shows Oracle's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Income / (Loss) Attributable to Common Shareholders	2,936	3,151	2,929	3,143	2,401	2,503	2,420	3,318	1,896	1,741	1,548
Consolidated Net Income / (Loss)	2,936	3,151	2,929	3,143	2,401	2,503	2,420	3,318	1,896	1,741	1,548
Net Income / (Loss) Continuing Operations	2,936	3,151	2,929	3,143	2,401	2,503	2,420	3,318	1,896	1,741	1,548
Total Pre-Tax Income	3,448	3,390	3,169	3,781	2,865	2,720	2,375	3,108	2,218	2,144	1,656
Total Operating Income	4,358	4,220	3,991	4,685	3,750	3,622	3,296	4,139	3,260	3,071	2,623
Total Gross Profit	11,051	11,141	10,548	11,523	10,611	10,454	10,055	11,418	10,174	10,098	9,461
Total Revenue	14,130	14,059	13,307	14,287	13,280	12,941	12,453	13,836	12,398	12,275	11,445
Operating Revenue	14,130	14,059	13,307	14,287	13,280	12,941	12,453	13,836	12,398	12,275	11,445
Total Cost of Revenue	3,079	2,918	2,759	2,764	2,669	2,487	2,398	2,418	2,224	2,177	1,984
Operating Cost of Revenue	3,079	2,918	2,759	2,764	2,669	2,487	2,398	2,418	2,224	2,177	1,984
Total Operating Expenses	6,693	6,921	6,557	6,838	6,861	6,832	6,759	7,279	6,914	7,027	6,838
Selling, General & Admin Expense	390	387	358	403	377	375	393	400	402	366	411
Marketing Expense	2,119	2,190	2,036	2,113	2,042	2,093	2,026	2,290	2,150	2,216	2,177
Research & Development Expense	2,429	2,471	2,306	2,225	2,248	2,226	2,216	2,226	2,146	2,158	2,093
Amortization Expense	548	591	624	743	749	755	763	870	886	907	919
Other Operating Expenses / (Income)	1,116	1,167	1,147	1,160	1,200	1,253	1,212	1,312	1,215	1,181	1,053
Restructuring Charge	91	115	86	194	245	130	149	181	115	199	185
Total Other Income / (Expense), net	-910	-830	-822	-904	-885	-902	-921	-1,031	-1,042	-927	-967
Interest Expense	892	866	842	878	876	888	872	954	908	856	787
Other Income / (Expense), net	-18	36	20	-26	-9.00	-14	-49	-77	-134	-71	-180
Income Tax Expense	512	239	240	638	464	217	-45	-210	322	403	108
Basic Earnings per Share	$1.05	$1.13	$1.06	$1.15	$0.87	$0.91	$0.89	$1.22	$0.70	$0.65	$0.58
Weighted Average Basic Shares Outstanding	2.80B	2.79B	2.76B	2.74B	2.75B	2.75B	2.73B	2.70B	2.70B	2.70B	2.69B
Diluted Earnings per Share	$1.02	$1.10	$1.03	$1.11	$0.85	$0.89	$0.86	$1.20	$0.68	$0.63	$0.56
Weighted Average Diluted Shares Outstanding	2.87B	2.87B	2.85B	2.82B	2.82B	2.82B	2.82B	2.77B	2.78B	2.75B	2.75B
Weighted Average Basic & Diluted Shares Outstanding	2.80B	2.80B	2.77B	2.76B	2.75B	2.75B	2.74B	2.71B	2.70B	2.70B	2.70B
Cash Dividends to Common per Share	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.40	$0.32	$0.32	$0.32

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015
Net Change in Cash & Equivalents	689	-11,618	-8,715	-7,141	16,725	-1,106	-164	1,632	-1,564	3,947
Net Cash From Operating Activities	18,673	17,165	9,539	15,887	13,139	14,551	15,386	14,126	13,685	14,580
Net Cash From Continuing Operating Activities	18,673	17,165	9,539	15,887	13,139	14,551	15,386	14,126	13,685	14,580
Net Income / (Loss) Continuing Operations	10,467	8,503	6,717	13,746	10,135	11,083	3,587	9,452	8,901	9,938
Consolidated Net Income / (Loss)	10,467	8,503	6,717	13,746	10,135	11,083	3,587	9,452	8,901	9,938
Depreciation Expense	3,129	2,526	1,972	1,537	1,382	1,230	1,165	1,000	871	712
Amortization Expense	3,010	3,582	1,150	1,379	1,586	1,689	1,620	1,451	1,638	2,149
Non-Cash Adjustments To Reconcile Net Income	4,694	4,208	2,833	1,798	1,829	2,000	1,780	1,605	1,310	1,316
Changes in Operating Assets and Liabilities, net	-2,627	-1,654	-3,133	-2,573	-1,793	-1,451	7,270	618	965	465
Net Cash From Investing Activities	-7,360	-36,484	11,220	-13,098	9,843	26,557	-5,625	-21,494	-5,154	-19,047
Net Cash From Continuing Investing Activities	-7,360	-36,484	11,220	-13,098	9,843	26,557	-5,625	-21,494	-5,154	-19,047
Purchase of Property, Plant & Equipment	-6,866	-8,695	-4,511	-2,135	-1,564	-1,660	-1,736	-2,021	-1,189	-1,391
Acquisitions	-63	-27,721	-148	-41	-124	-363	-1,724	-11,221	-650	-6,239
Purchase of Investments	-1,003	-1,181	-10,272	-37,982	-5,731	-1,400	-25,282	-25,867	-24,562	-31,421
Sale and/or Maturity of Investments	572	1,113	26,151	27,060	17,262	29,980	23,117	17,615	21,247	20,004
Net Cash From Financing Activities	-10,554	7,910	-29,126	-10,378	-6,132	-42,056	-9,982	9,086	-9,980	9,606
Net Cash From Continuing Financing Activities	-10,554	7,910	-29,126	-10,378	-6,132	-42,056	-9,982	9,086	-9,980	9,606
Repayment of Debt	-3,496	-20,605	-8,810	-2,435	-4,633	-4,636	-9,834	-4,352	-2,000	-1,500
Repurchase of Common Equity	-1,202	-1,300	-16,248	-20,934	-19,240	-36,140	-11,347	-3,561	-10,440	-8,087
Payment of Dividends	-4,391	-3,668	-3,457	-3,063	-3,070	-2,932	-3,140	-2,631	-2,626	-2,451
Issuance of Debt	-167	33,494	0.00	14,934	19,888	0.00	12,443	17,732	3,750	19,842
Issuance of Common Equity	742	1,192	482	1,786	1,588	2,155	2,402	2,181	1,425	1,816
Other Financing Activities, net	-2,040	-1,203	-1,093	-666	-665	-503	-506	-283	-89	-14
Effect of Exchange Rate Changes	-70	-	-348	448	-	-	-	-	-115	-1,192
Cash Interest Paid	3,655	3,250	2,735	2,408	1,972	2,059	1,910	1,612	1,616	1,022
Cash Income Taxes Paid	3,560	3,009	2,567	3,189	3,218	2,901	1,562	1,983	2,331	3,055

This table details how cash moves in and out of Oracle's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Change in Cash & Equivalents	6,465	325	162	973	1,237	-3,369	1,848	1,546	1,406	-3,635	-10,935
Net Cash From Operating Activities	5,933	1,304	7,427	6,081	5,475	143	6,974	5,647	4,275	849	6,394
Net Cash From Continuing Operating Activities	5,933	1,304	7,427	6,081	5,475	143	6,974	5,647	4,275	849	6,394
Net Income / (Loss) Continuing Operations	2,936	3,151	2,929	3,144	2,400	2,503	2,420	3,319	1,895	1,741	1,548
Consolidated Net Income / (Loss)	2,936	3,151	2,929	3,144	2,400	2,503	2,420	3,319	1,895	1,741	1,548
Depreciation Expense	1,003	908	804	811	808	798	712	716	672	591	547
Amortization Expense	548	591	624	743	749	755	763	870	886	907	919
Non-Cash Adjustments To Reconcile Net Income	1,322	1,488	986	1,136	1,349	1,191	1,018	1,138	1,122	1,042	906
Changes in Operating Assets and Liabilities, net	124	-4,834	2,084	247	169	-5,104	2,061	-396	-300	-3,432	2,474
Net Cash From Investing Activities	-5,976	-3,788	-2,765	-2,766	-1,783	-1,249	-1,562	-1,612	-2,778	-2,658	-29,436
Net Cash From Continuing Investing Activities	-5,976	-3,788	-2,765	-2,766	-1,783	-1,249	-1,562	-1,612	-2,778	-2,658	-29,436
Purchase of Property, Plant & Equipment	-5,862	-3,970	-2,303	-2,798	-1,674	-1,080	-1,314	-1,913	-2,628	-2,435	-1,719
Purchase of Investments	-202	-159	-477	-329	-159	-182	-333	-260	-318	-546	-57
Sale and/or Maturity of Investments	88	341	15	365	50	72	85	561	90	324	138
Net Cash From Financing Activities	6,559	2,938	-4,585	-2,274	-2,463	-2,289	-3,528	-2,440	-105	-1,855	12,310
Net Cash From Continuing Financing Activities	6,559	2,938	-4,585	-2,274	-2,463	-2,289	-3,528	-2,440	-105	-1,855	12,310
Repayment of Debt	-94	-1,689	-8,287	-966	-810	-1,934	-1,535	-1,478	-2,379	-10,738	-6,010
Repurchase of Common Equity	-150	-150	-150	-152	-450	-450	-150	-150	-150	-448	-552
Payment of Dividends	-1,119	-1,118	-1,103	-1,102	-1,099	-1,099	-1,091	-1,082	-863	-863	-860
Issuance of Debt	7,711	5,814	5,627	-167	-	1,749	0.00	-	3,334	10,114	20,046
Issuance of Common Equity	213	128	179	288	28	118	308	433	98	146	515
Other Financing Activities, net	-2.00	-47	-851	-175	-132	-673	-1,060	-163	-145	-66	-829
Effect of Exchange Rate Changes	-51	-129	85	-68	8.00	26	-36	-	14	29	-203

This table presents Oracle's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015
Total Assets	140,976	134,384	109,297	131,107	115,438	108,709	137,851	134,991	112,180	110,903
Total Current Assets	22,554	21,004	31,633	55,567	52,140	46,386	76,159	74,515	64,313	62,520
Cash & Equivalents	10,454	9,765	21,383	30,098	37,239	20,514	21,620	21,784	20,152	21,716
Short-Term Investments	207	422	519	16,456	5,818	17,313	45,641	44,294	35,973	32,652
Accounts Receivable	7,874	6,915	5,953	5,409	5,551	5,134	5,136	5,300	5,385	5,618
Prepaid Expenses	4,019	3,902	3,778	3,604	3,532	3,425	3,762	3,137	2,591	-
Plant, Property, & Equipment, net	21,536	17,069	9,716	7,049	6,244	6,252	5,897	5,315	4,000	3,686
Total Noncurrent Assets	96,886	96,311	67,948	68,491	57,054	56,071	55,795	55,161	43,867	44,697
Goodwill	62,230	62,261	43,811	43,935	43,769	43,779	43,755	43,045	34,590	34,087
Intangible Assets	6,890	9,837	1,440	2,430	3,738	5,279	6,670	7,679	4,943	6,406
Noncurrent Deferred & Refundable Income Taxes	12,273	12,226	12,782	13,636	3,252	2,696	1,395	1,143	1,291	1,458
Other Noncurrent Operating Assets	15,493	11,987	9,915	8,490	6,295	4,317	3,975	3,294	3,043	2,746
Total Liabilities & Shareholders' Equity	140,976	134,384	109,297	131,107	115,438	108,709	137,851	134,991	112,180	110,903
Total Liabilities	131,737	132,828	115,065	125,155	102,721	86,346	90,978	80,745	64,390	61,805
Total Current Liabilities	31,544	23,090	19,511	24,164	17,200	18,630	19,124	24,178	17,208	15,206
Short-Term Debt	10,605	4,061	3,749	8,250	2,371	4,494	4,491	9,797	3,750	1,999
Accounts Payable	2,357	1,204	1,317	745	637	580	529	599	504	806
Current Deferred Revenue	9,313	8,970	8,357	8,775	8,002	8,374	8,341	8,233	7,655	7,245
Current Employee Benefit Liabilities	1,916	2,053	1,944	2,017	1,453	1,628	1,806	1,966	1,966	1,839
Other Current Liabilities	7,353	6,802	4,144	4,377	4,737	3,554	3,957	3,583	3,333	3,317
Total Noncurrent Liabilities	100,193	109,738	95,554	100,991	85,521	67,716	71,854	56,567	47,182	46,599
Long-Term Debt	76,264	86,420	72,110	75,995	69,226	51,673	56,128	48,112	40,105	39,959
Noncurrent Deferred Revenue	10,817	11,077	12,210	12,345	12,463	13,295	13,429	5,681	4,908	4,386
Noncurrent Deferred & Payable Income Tax Liabilities	3,692	5,772	6,031	7,864	41	-	-	-	-	-
Other Noncurrent Operating Liabilities	9,420	6,469	5,203	4,787	3,791	2,748	2,297	2,774	2,169	2,254
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	9,239	1,556	-5,768	5,952	12,717	22,363	46,873	54,246	47,790	49,098
Total Preferred & Common Equity	8,704	1,073	-6,220	5,238	12,074	21,785	46,372	53,860	47,289	48,663
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	8,704	1,073	-6,220	5,238	12,074	21,785	46,372	53,860	47,289	48,663
Common Stock	32,764	30,215	26,808	26,533	26,486	26,909	28,950	27,065	24,217	23,156
Retained Earnings	-22,628	-27,620	-31,336	-20,120	-12,696	-3,496	19,111	27,598	23,888	26,503
Accumulated Other Comprehensive Income / (Loss)	-1,432	-1,522	-1,692	-1,175	-1,716	-1,628	-1,689	-803	-816	-996
Noncontrolling Interest	535	483	452	714	643	578	501	386	501	435

This table presents Oracle's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Total Assets	161,378	148,483	144,214	140,976	137,082	134,324	136,662	134,384	131,620	128,469	130,309
Total Current Assets	30,116	23,503	23,072	22,554	21,063	19,289	22,166	21,004	18,696	17,561	21,004
Cash & Equivalents	17,406	10,941	10,616	10,454	9,481	8,244	11,613	9,765	8,219	6,813	10,448
Short-Term Investments	417	370	295	207	423	446	470	422	550	537	772
Accounts Receivable	8,051	8,177	8,021	7,874	7,297	6,804	6,519	6,915	6,213	6,197	5,937
Prepaid Expenses	4,242	4,015	4,140	4,019	3,862	3,795	3,564	3,902	3,714	4,014	3,847
Plant, Property, & Equipment, net	31,970	26,432	23,094	21,536	19,117	18,009	17,644	17,069	16,345	14,351	12,280
Total Noncurrent Assets	99,292	98,548	98,048	96,886	96,902	97,026	96,852	96,311	96,579	96,557	97,025
Goodwill	62,171	62,204	62,249	62,230	62,222	62,231	62,206	62,261	61,499	61,513	61,629
Intangible Assets	5,131	5,679	6,270	6,890	7,629	8,378	9,074	9,837	10,707	11,593	12,499
Noncurrent Deferred & Refundable Income Taxes	11,799	11,984	12,219	12,273	12,688	12,758	12,243	12,226	12,153	12,091	12,065
Other Noncurrent Operating Assets	20,191	18,681	17,310	15,493	14,363	13,659	13,329	11,987	12,220	11,360	10,832
Total Liabilities & Shareholders' Equity	161,378	148,483	144,214	140,976	137,082	134,324	136,662	134,384	131,620	128,469	130,309
Total Liabilities	144,117	134,247	132,945	131,737	130,900	129,946	133,821	132,828	133,532	132,245	135,758
Total Current Liabilities	29,623	29,052	32,045	31,544	24,885	24,407	25,357	23,090	22,880	27,106	34,819
Short-Term Debt	8,167	8,162	9,201	10,605	5,510	6,321	4,499	4,061	5,415	9,746	16,097
Accounts Payable	2,423	2,679	2,207	2,357	1,658	1,107	1,034	1,204	1,610	1,647	1,461
Current Deferred Revenue	9,019	9,430	11,455	9,313	8,931	8,878	11,120	8,970	8,598	8,705	10,473
Current Employee Benefit Liabilities	1,839	1,653	1,772	1,916	1,796	1,706	1,818	2,053	1,736	1,780	1,958
Other Current Liabilities	8,175	7,128	7,410	7,353	6,990	6,395	6,886	6,802	5,521	5,228	4,830
Total Noncurrent Liabilities	114,494	105,195	100,900	100,193	106,015	105,539	108,464	109,738	110,652	105,139	100,939
Long-Term Debt	88,109	80,462	75,314	76,264	82,470	82,468	84,442	86,420	86,396	81,173	75,480
Noncurrent Deferred Revenue	9,813	9,553	11,038	10,817	10,451	10,046	11,201	11,077	11,335	11,128	12,128
Noncurrent Deferred & Payable Income Tax Liabilities	2,208	2,864	3,442	3,692	4,483	5,244	5,281	5,772	6,814	7,165	7,693
Other Noncurrent Operating Liabilities	14,364	12,316	11,106	9,420	8,611	7,781	7,540	6,469	6,107	5,673	5,638
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	17,261	14,236	11,269	9,239	6,182	4,378	2,841	1,556	-1,912	-3,776	-5,449
Total Preferred & Common Equity	16,730	13,746	10,816	8,704	5,623	3,866	2,370	1,073	-2,421	-4,246	-5,875
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	16,730	13,746	10,816	8,704	5,623	3,866	2,370	1,073	-2,421	-4,246	-5,875
Common Stock	35,691	34,310	33,083	32,764	31,622	30,724	30,295	30,215	28,994	28,148	27,224
Retained Earnings	-17,368	-19,045	-20,939	-22,628	-24,533	-25,431	-26,428	-27,620	-29,721	-30,617	-31,134
Accumulated Other Comprehensive Income / (Loss)	-1,593	-1,519	-1,328	-1,432	-1,466	-1,427	-1,497	-1,522	-1,694	-1,777	-1,965
Noncontrolling Interest	531	490	453	535	559	512	471	483	509	470	426

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	5/31/2024	5/31/2023	5/31/2022	5/31/2021	5/31/2020	5/31/2019	5/31/2018	5/31/2017	5/31/2016	5/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.02%	17.71%	4.84%	3.61%	-1.11%	0.31%	4.21%	2.01%	-3.08%	-0.13%
EBITDA Growth	14.17%	38.54%	-26.53%	8.13%	-1.41%	0.20%	8.19%	3.31%	-8.43%	-3.93%
EBIT Growth	20.77%	21.41%	-32.86%	10.22%	-2.03%	-0.69%	7.20%	4.41%	-7.64%	-4.39%
NOPAT Growth	12.20%	27.14%	-40.36%	37.79%	-4.52%	219.30%	-63.35%	6.58%	-8.71%	-8.96%
Net Income Growth	23.10%	26.59%	-51.13%	35.63%	-8.55%	208.98%	-62.05%	6.19%	-10.43%	-9.28%
EPS Growth	20.85%	27.39%	-47.03%	47.73%	3.70%	249.41%	-62.05%	8.21%	-6.33%	-7.14%
Operating Cash Flow Growth	8.79%	79.95%	-39.96%	20.91%	-9.70%	-5.43%	8.92%	3.22%	-6.14%	0.96%
Free Cash Flow Firm Growth	147.01%	-525.09%	-63.15%	23.20%	-5.40%	21.50%	9,125.76%	-100.98%	61.89%	-35.43%
Invested Capital Growth	4.39%	69.85%	10.42%	5.78%	1.36%	1.17%	-12.69%	29.72%	-3.18%	12.11%
Revenue Q/Q Growth	0.86%	4.16%	1.46%	1.98%	-1.75%	0.31%	0.14%	0.97%	-0.30%	-1.59%
EBITDA Q/Q Growth	2.71%	2.68%	-3.19%	3.42%	-0.86%	-0.07%	0.19%	2.89%	-0.41%	-4.60%
EBIT Q/Q Growth	4.07%	-2.06%	-4.80%	3.87%	-0.82%	-0.44%	0.35%	2.36%	0.55%	-5.44%
NOPAT Q/Q Growth	-3.86%	4.41%	-5.33%	4.95%	-4.11%	5.47%	-2.70%	6.79%	0.23%	-7.97%
Net Income Q/Q Growth	-1.64%	1.55%	-11.16%	7.14%	-5.80%	4.37%	-1.99%	5.99%	0.66%	-8.21%
EPS Q/Q Growth	-2.37%	0.99%	-6.95%	9.11%	-1.91%	8.00%	1.19%	6.67%	2.48%	-7.53%
Operating Cash Flow Q/Q Growth	2.38%	10.72%	-8.24%	8.38%	-5.79%	-1.61%	1.28%	5.00%	-6.92%	3.90%
Free Cash Flow Firm Q/Q Growth	-9.17%	5.17%	-21.04%	5.76%	-6.11%	20.46%	-12.37%	39.74%	-1.32%	-1.24%
Invested Capital Q/Q Growth	1.41%	0.89%	2.94%	1.33%	1.37%	0.83%	4.41%	0.96%	-0.43%	-0.88%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	80.52%	82.38%	85.43%	86.85%	86.89%	86.98%	79.53%	80.28%	79.81%	80.30%
EBITDA Margin	40.40%	37.51%	31.87%	45.48%	43.58%	43.71%	43.76%	42.15%	41.62%	44.05%
Operating Margin	28.99%	26.21%	25.74%	37.58%	35.57%	34.26%	33.68%	34.17%	34.02%	36.29%
EBIT Margin	28.80%	25.29%	24.51%	38.28%	35.98%	36.32%	36.69%	35.66%	34.84%	36.56%
Profit (Net Income) Margin	19.76%	17.02%	15.83%	33.96%	25.94%	28.05%	9.11%	25.01%	24.03%	26.00%
Tax Burden Percent	89.15%	93.17%	87.82%	105.75%	84.02%	90.34%	28.87%	80.92%	77.79%	77.43%
Interest Burden Percent	76.96%	72.25%	73.52%	83.89%	85.81%	85.49%	85.99%	86.66%	88.64%	91.82%
Effective Tax Rate	10.85%	6.83%	12.18%	-5.75%	15.98%	9.66%	71.13%	19.08%	22.21%	22.57%
Return on Invested Capital (ROIC)	16.36%	18.76%	20.90%	37.90%	28.49%	30.22%	8.87%	25.61%	27.16%	30.95%
ROIC Less NNEP Spread (ROIC-NNEP)	12.25%	13.26%	14.62%	30.83%	21.92%	10.65%	12.15%	35.38%	34.48%	36.87%
Return on Net Nonoperating Assets (RNNOA)	177.56%	-422.51%	7,280.19%	109.36%	29.29%	1.80%	-1.78%	-7.09%	-8.78%	-10.36%
Return on Equity (ROE)	193.92%	-403.75%	7,301.09%	147.26%	57.78%	32.02%	7.09%	18.53%	18.37%	20.59%
Cash Return on Invested Capital (CROIC)	12.06%	-33.01%	11.00%	32.28%	27.14%	29.05%	22.42%	-0.26%	30.39%	19.53%
Operating Return on Assets (OROA)	11.08%	10.37%	8.66%	12.57%	12.54%	11.64%	10.59%	10.91%	11.57%	13.90%
Return on Assets (ROA)	7.60%	6.98%	5.59%	11.15%	9.04%	8.99%	2.63%	7.65%	7.98%	9.88%
Return on Common Equity (ROCE)	175.64%	-493.38%	-38,965.58%	136.56%	55.77%	31.52%	7.03%	18.37%	18.20%	20.37%
Return on Equity Simple (ROE_SIMPLE)	120.26%	792.45%	-107.99%	262.43%	83.94%	50.87%	7.74%	17.55%	18.82%	20.42%
Net Operating Profit after Tax (NOPAT)	13,687	12,199	9,595	16,087	11,675	12,228	3,830	10,450	9,805	10,741
NOPAT Margin	25.84%	24.42%	22.61%	39.74%	29.88%	30.95%	9.72%	27.65%	26.47%	28.10%
Net Nonoperating Expense Percent (NNEP)	4.12%	5.51%	6.28%	7.07%	6.57%	19.57%	-3.27%	-9.76%	-7.33%	-5.92%
Cost of Revenue to Revenue	19.48%	17.62%	14.57%	13.16%	13.11%	13.02%	20.47%	19.72%	20.19%	19.70%
SG&A Expenses to Revenue	2.92%	3.16%	3.10%	3.10%	3.02%	3.20%	3.26%	3.10%	3.12%	2.82%
R&D to Revenue	16.83%	17.26%	17.01%	16.12%	15.53%	15.25%	15.45%	16.28%	15.62%	14.45%
Operating Expenses to Revenue	51.53%	56.17%	59.68%	49.26%	51.32%	52.72%	45.85%	46.11%	45.79%	44.01%
Earnings before Interest and Taxes (EBIT)	15,255	12,631	10,404	15,495	14,058	14,350	14,449	13,478	12,909	13,977
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21,394	18,739	13,526	18,411	17,026	17,269	17,234	15,929	15,418	16,838
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	36.90	262.05	0.00	41.26	13.15	7.30	3.72	3.09	3.09	3.37
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	53.06	18.86	20.07
Price to Revenue (P/Rev)	6.06	5.63	4.37	5.34	4.06	4.03	4.38	4.40	3.95	4.29
Price to Earnings (P/E)	30.69	33.07	27.60	15.72	15.67	14.35	48.12	17.60	16.44	16.50
Dividend Yield	1.37%	1.31%	1.84%	1.39%	1.91%	1.74%	1.80%	1.58%	1.70%	1.36%
Earnings Yield	3.26%	3.02%	3.62%	6.36%	6.38%	6.97%	2.08%	5.68%	6.08%	6.06%
Enterprise Value to Invested Capital (EV/IC)	4.66	4.42	4.98	5.83	4.56	4.37	4.14	3.44	3.79	4.14
Enterprise Value to Revenue (EV/Rev)	7.51	7.25	5.65	6.29	4.81	4.51	4.23	4.20	3.63	3.98
Enterprise Value to EBITDA (EV/EBITDA)	18.60	19.32	17.73	13.82	11.04	10.31	9.66	9.96	8.73	9.03
Enterprise Value to EBIT (EV/EBIT)	26.09	28.66	23.05	16.43	13.37	12.41	11.52	11.77	10.42	10.88
Enterprise Value to NOPAT (EV/NOPAT)	29.07	29.67	24.99	15.82	16.10	14.56	43.47	15.18	13.72	14.15
Enterprise Value to Operating Cash Flow (EV/OCF)	21.31	21.09	25.14	16.02	14.31	12.23	10.82	11.23	9.83	10.43
Enterprise Value to Free Cash Flow (EV/FCFF)	39.44	0.00	47.49	18.58	16.90	15.14	17.21	0.00	12.26	22.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	9.40	58.15	-13.15	14.15	5.63	2.51	1.29	1.07	0.92	0.85
Long-Term Debt to Equity	8.25	55.54	-12.50	12.77	5.44	2.31	1.20	0.89	0.84	0.81
Financial Leverage	14.50	-31.87	498.09	3.55	1.34	0.17	-0.15	-0.20	-0.25	-0.28
Leverage Ratio	25.51	-57.85	1,306.54	13.21	6.39	3.56	2.70	2.42	2.30	2.08
Compound Leverage Factor	19.63	-41.80	960.57	11.08	5.48	3.04	2.32	2.10	2.04	1.91
Debt to Total Capital	90.39%	98.31%	108.23%	93.40%	84.92%	71.52%	56.39%	51.63%	47.85%	46.08%
Short-Term Debt to Total Capital	11.03%	4.41%	5.35%	9.15%	2.81%	5.72%	4.18%	8.74%	4.09%	2.20%
Long-Term Debt to Total Capital	79.35%	93.90%	102.88%	84.25%	82.11%	65.80%	52.22%	42.90%	43.76%	43.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.56%	0.52%	0.64%	0.79%	0.76%	0.74%	0.47%	0.34%	0.55%	0.48%
Common Equity to Total Capital	9.06%	1.17%	-8.87%	5.81%	14.32%	27.74%	43.14%	48.02%	51.60%	53.44%
Debt to EBITDA	4.06	4.83	5.61	4.58	4.21	3.25	3.52	3.64	2.84	2.49
Net Debt to EBITDA	3.56	4.28	3.99	2.05	1.68	1.06	-0.39	-0.51	-0.80	-0.74
Long-Term Debt to EBITDA	3.56	4.61	5.33	4.13	4.07	2.99	3.26	3.02	2.60	2.37
Debt to NOPAT	6.35	7.42	7.91	5.24	6.13	4.59	15.83	5.54	4.47	3.91
Net Debt to NOPAT	5.57	6.58	5.62	2.34	2.44	1.50	-1.73	-0.78	-1.25	-1.16
Long-Term Debt to NOPAT	5.57	7.08	7.52	4.72	5.93	4.23	14.66	4.60	4.09	3.72
Altman Z-Score	1.89	1.65	1.40	1.81	1.88	2.17	2.46	2.58	2.88	3.20
Noncontrolling Interest Sharing Ratio	9.43%	-22.20%	633.70%	7.27%	3.48%	1.56%	0.88%	0.87%	0.97%	1.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.72	0.91	1.62	2.30	3.03	2.49	3.98	3.08	3.74	4.11
Quick Ratio	0.59	0.74	1.43	2.15	2.83	2.31	3.79	2.95	3.57	3.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	10,090	-21,462	5,049	13,701	11,121	11,756	9,676	-107	10,973	6,778
Operating Cash Flow to CapEx	271.96%	197.41%	211.46%	744.12%	840.09%	876.57%	886.29%	698.96%	1,150.97%	1,048.17%
Free Cash Flow to Firm to Interest Expense	2.87	-6.12	1.83	5.49	5.57	5.65	4.78	-0.06	7.48	5.93
Operating Cash Flow to Interest Expense	5.31	4.90	3.46	6.37	6.59	6.99	7.60	7.86	9.33	12.76
Operating Cash Flow Less CapEx to Interest Expense	3.36	2.42	1.83	5.51	5.80	6.19	6.74	6.73	8.52	11.54
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.38	0.41	0.35	0.33	0.35	0.32	0.29	0.31	0.33	0.38
Accounts Receivable Turnover	7.16	7.76	7.47	7.39	7.31	7.69	7.55	7.07	6.73	6.53
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	28.44	29.95
Fixed Asset Turnover	2.74	3.73	5.06	6.09	6.25	6.50	7.03	8.11	9.64	11.33
Accounts Payable Turnover	5.80	6.98	6.00	7.71	8.42	9.27	14.29	13.51	11.42	11.80
Days Sales Outstanding (DSO)	50.96	47.01	48.86	49.41	49.91	47.44	48.36	51.60	54.20	55.88
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.84	12.19
Days Payable Outstanding (DPO)	62.99	52.26	60.84	47.36	43.36	39.36	25.54	27.01	31.97	30.94
Cash Conversion Cycle (CCC)	-12.02	-5.25	-11.98	2.05	6.55	8.08	22.82	24.59	35.07	37.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	85,447	81,850	48,189	43,643	41,257	40,703	40,231	46,077	35,520	36,688
Invested Capital Turnover	0.63	0.77	0.92	0.95	0.95	0.98	0.91	0.93	1.03	1.10
Increase / (Decrease) in Invested Capital	3,597	33,661	4,546	2,386	554	472	-5,846	10,557	-1,168	3,963
Enterprise Value (EV)	397,934	361,955	239,781	254,523	187,962	178,012	166,476	158,613	134,539	152,025
Market Capitalization	321,191	281,178	185,372	216,118	158,779	159,094	172,617	166,396	146,308	164,000
Book Value per Share	$3.17	$0.40	($2.33)	$1.82	$3.83	$6.37	$11.36	$13.09	$11.40	$11.14
Tangible Book Value per Share	($21.98)	($26.31)	($19.29)	($14.26)	($11.24)	($7.98)	($0.99)	$0.76	$1.87	$1.87
Total Capital	96,108	92,037	70,091	90,197	84,314	78,530	107,492	112,155	91,645	91,056
Total Debt	86,869	90,481	75,859	84,245	71,597	56,167	60,619	57,909	43,855	41,958
Total Long-Term Debt	76,264	86,420	72,110	75,995	69,226	51,673	56,128	48,112	40,105	39,959
Net Debt	76,208	80,294	53,957	37,691	28,540	18,340	-6,642	-8,169	-12,270	-12,410
Capital Expenditures (CapEx)	6,866	8,695	4,511	2,135	1,564	1,660	1,736	2,021	1,189	1,391
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9,046	-8,212	-6,031	-6,901	-5,746	-5,577	-5,735	-5,944	-5,270	-5,055
Debt-free Net Working Capital (DFNWC)	1,615	1,975	15,871	39,653	37,311	32,250	61,526	60,134	50,855	49,313
Net Working Capital (NWC)	-8,990	-2,086	12,122	31,403	34,940	27,756	57,035	50,337	47,105	47,314
Net Nonoperating Expense (NNE)	3,220	3,696	2,878	2,341	1,540	1,145	243	998	904	803
Net Nonoperating Obligations (NNO)	76,208	80,294	53,957	37,691	28,540	18,340	-6,642	-8,169	-12,270	-12,410
Total Depreciation and Amortization (D&A)	6,139	6,108	3,122	2,916	2,968	2,919	2,785	2,451	2,509	2,861
Debt-free, Cash-free Net Working Capital to Revenue	-17.08%	-16.44%	-14.21%	-17.05%	-14.71%	-14.12%	-14.56%	-15.73%	-14.23%	-13.22%
Debt-free Net Working Capital to Revenue	3.05%	3.95%	37.40%	97.96%	95.50%	81.63%	156.22%	159.12%	137.27%	129.00%
Net Working Capital to Revenue	-16.97%	-4.18%	28.56%	77.58%	89.43%	70.26%	144.82%	133.19%	127.15%	123.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.82	$3.15	$2.49	$4.67	$3.16	$3.05	$0.93	$2.27	$2.11	$2.26
Adjusted Weighted Average Basic Shares Outstanding	2.74B	2.70B	2.70B	2.95B	3.21B	3.63B	4.12B	4.12B	4.22B	4.40B
Adjusted Diluted Earnings per Share	$3.71	$3.07	$2.41	$4.55	$3.08	$2.97	$0.90	$2.21	$2.07	$2.21
Adjusted Weighted Average Diluted Shares Outstanding	2.82B	2.77B	2.79B	3.02B	3.29B	3.73B	4.24B	4.22B	4.31B	4.50B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$3.16	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.76B	2.71B	2.66B	2.79B	3.07B	3.34B	3.98B	4.14B	4.12B	4.34B
Normalized Net Operating Profit after Tax (NOPAT)	14,327	12,833	13,901	11,047	11,932	12,668	9,733	10,908	10,194	11,065
Normalized NOPAT Margin	27.05%	25.69%	32.75%	27.29%	30.54%	32.06%	24.71%	28.86%	27.52%	28.95%
Pre Tax Income Margin	22.17%	18.27%	18.02%	32.11%	30.88%	31.05%	31.55%	30.91%	30.89%	33.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.34	3.60	3.78	6.21	7.05	6.89	7.14	7.50	8.80	12.23
NOPAT to Interest Expense	3.90	3.48	3.48	6.45	5.85	5.87	1.89	5.81	6.68	9.40
EBIT Less CapEx to Interest Expense	2.39	1.12	2.14	5.35	6.26	6.10	6.28	6.37	7.99	11.01
NOPAT Less CapEx to Interest Expense	1.94	1.00	1.85	5.59	5.07	5.08	1.03	4.69	5.87	8.18
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	41.95%	43.14%	51.47%	22.28%	30.29%	26.45%	87.54%	27.84%	29.50%	24.66%
Augmented Payout Ratio	53.43%	58.43%	293.36%	174.57%	220.13%	352.54%	403.88%	65.51%	146.79%	106.04%

This table displays calculated financial ratios and metrics derived from Oracle's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.40%	8.64%	6.86%	3.26%	7.11%	5.43%	8.81%	16.87%	17.93%	18.48%	17.65%
EBITDA Growth	11.19%	11.51%	15.18%	10.00%	13.11%	14.74%	20.80%	9.48%	9.39%	7,855.17%	-5.65%
EBIT Growth	16.01%	17.96%	23.53%	14.70%	19.67%	20.27%	32.91%	-6.15%	-10.86%	467.20%	-27.85%
NOPAT Growth	18.08%	17.68%	9.83%	-11.86%	12.77%	33.66%	36.97%	11.60%	-10.71%	532.34%	-21.93%
Net Income Growth	22.28%	25.89%	21.03%	-5.27%	26.64%	43.77%	56.33%	4.08%	-18.24%	239.62%	-37.00%
EPS Growth	20.00%	23.60%	19.77%	-7.50%	25.00%	41.27%	53.57%	2.56%	-19.05%	236.96%	-34.88%
Operating Cash Flow Growth	8.37%	811.89%	6.50%	7.69%	28.07%	-83.16%	9.07%	41.71%	11.18%	123.06%	18.61%
Free Cash Flow Firm Growth	-52,895.12%	-133.13%	-3.68%	101.02%	100.05%	95.69%	95.25%	-4,885.81%	-4,984.31%	-449.59%	-5,813.45%
Invested Capital Growth	13.60%	8.37%	6.49%	4.39%	3.86%	5.87%	6.40%	69.85%	73.31%	73.71%	77.18%
Revenue Q/Q Growth	0.51%	5.65%	-6.86%	7.58%	2.62%	3.92%	-10.00%	11.60%	1.00%	7.25%	-3.33%
EBITDA Q/Q Growth	2.36%	5.81%	-12.46%	17.27%	2.65%	9.30%	-16.40%	20.58%	4.14%	15.07%	-24.23%
EBIT Q/Q Growth	1.97%	6.11%	-13.91%	24.54%	3.69%	11.12%	-20.06%	29.94%	4.20%	22.80%	-43.55%
NOPAT Q/Q Growth	-5.39%	6.34%	-5.28%	23.92%	-5.71%	-0.76%	-23.99%	58.56%	11.75%	1.71%	-38.07%
Net Income Q/Q Growth	-6.82%	7.58%	-6.81%	30.90%	-4.08%	3.43%	-27.06%	75.00%	8.90%	12.47%	-51.44%
EPS Q/Q Growth	-7.27%	6.80%	-7.21%	30.59%	-4.49%	3.49%	-28.33%	76.47%	7.94%	12.50%	-52.14%
Operating Cash Flow Q/Q Growth	354.98%	-82.44%	22.13%	11.07%	3,728.67%	-97.95%	23.50%	32.09%	403.53%	-86.72%	60.45%
Free Cash Flow Firm Q/Q Growth	-145.91%	-112.05%	-599.31%	1,927.66%	101.09%	5.70%	95.10%	7.26%	-0.53%	-3.93%	-5,045.35%
Invested Capital Q/Q Growth	4.55%	7.87%	-0.67%	1.41%	-0.26%	6.00%	-2.63%	0.89%	1.68%	6.52%	55.45%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	78.21%	79.24%	79.27%	80.65%	79.90%	80.78%	80.74%	82.52%	82.06%	82.26%	82.66%
EBITDA Margin	41.69%	40.93%	40.87%	43.49%	39.89%	39.88%	37.92%	40.82%	37.78%	36.64%	34.15%
Operating Margin	30.84%	30.02%	29.99%	32.79%	28.24%	27.99%	26.47%	29.91%	26.29%	25.02%	22.92%
EBIT Margin	30.71%	30.27%	30.14%	32.61%	28.17%	27.88%	26.07%	29.36%	25.21%	24.44%	21.35%
Profit (Net Income) Margin	20.78%	22.41%	22.01%	22.00%	18.08%	19.34%	19.43%	23.98%	15.29%	14.18%	13.53%
Tax Burden Percent	85.15%	92.95%	92.43%	83.13%	83.80%	92.02%	101.89%	106.76%	85.48%	81.20%	93.48%
Interest Burden Percent	79.45%	79.65%	79.01%	81.15%	76.58%	75.39%	73.14%	76.51%	70.95%	71.47%	67.79%
Effective Tax Rate	14.85%	7.05%	7.57%	16.87%	16.20%	7.98%	-1.89%	-6.76%	14.52%	18.80%	6.52%
Return on Invested Capital (ROIC)	16.28%	17.41%	18.13%	17.26%	15.03%	16.19%	17.78%	24.54%	16.85%	14.89%	16.15%
ROIC Less NNEP Spread (ROIC-NNEP)	15.29%	16.43%	17.12%	16.30%	14.11%	15.18%	16.59%	22.90%	15.56%	13.81%	14.68%
Return on Net Nonoperating Assets (RNNOA)	102.09%	138.97%	182.55%	236.29%	532.26%	4,125.70%	-999.80%	-729.79%	-212.22%	-143.03%	-276.25%
Return on Equity (ROE)	118.37%	156.39%	200.68%	253.54%	547.29%	4,141.89%	-982.02%	-705.25%	-195.37%	-128.14%	-260.10%
Cash Return on Invested Capital (CROIC)	4.18%	8.61%	10.79%	12.06%	13.43%	11.25%	10.76%	-33.01%	-35.38%	-34.75%	-40.54%
Operating Return on Assets (OROA)	11.48%	11.76%	11.55%	12.54%	11.01%	10.95%	9.95%	12.04%	10.07%	9.57%	7.44%
Return on Assets (ROA)	7.77%	8.71%	8.43%	8.46%	7.07%	7.60%	7.42%	9.83%	6.10%	5.55%	4.72%
Return on Common Equity (ROCE)	112.87%	147.97%	187.54%	229.63%	410.40%	-2,614.48%	-1,319.77%	-861.81%	-214.55%	-136.85%	-293.19%
Return on Equity Simple (ROE_SIMPLE)	72.68%	84.56%	101.48%	0.00%	189.26%	262.21%	395.57%	0.00%	-345.85%	-207.16%	-98.86%
Net Operating Profit after Tax (NOPAT)	3,711	3,922	3,689	3,894	3,143	3,333	3,358	4,419	2,787	2,494	2,452
NOPAT Margin	26.26%	27.90%	27.72%	27.26%	23.66%	25.76%	26.97%	31.94%	22.48%	20.32%	21.42%
Net Nonoperating Expense Percent (NNEP)	0.99%	0.98%	1.01%	0.96%	0.92%	1.01%	1.19%	1.64%	1.29%	1.08%	1.46%
Return On Investment Capital (ROIC_SIMPLE)	3.27%	3.81%	-	-	-	3.58%	-	-	-	-	-
Cost of Revenue to Revenue	21.79%	20.76%	20.73%	19.35%	20.10%	19.22%	19.26%	17.48%	17.94%	17.74%	17.34%
SG&A Expenses to Revenue	2.76%	2.75%	2.69%	2.82%	2.84%	2.90%	3.16%	2.89%	3.24%	2.98%	3.59%
R&D to Revenue	17.19%	17.58%	17.33%	15.57%	16.93%	17.20%	17.79%	16.09%	17.31%	17.58%	18.29%
Operating Expenses to Revenue	47.37%	49.23%	49.27%	47.86%	51.66%	52.79%	54.28%	52.61%	55.77%	57.25%	59.75%
Earnings before Interest and Taxes (EBIT)	4,340	4,256	4,011	4,659	3,741	3,608	3,247	4,062	3,126	3,000	2,443
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,891	5,755	5,439	6,213	5,298	5,161	4,722	5,648	4,684	4,498	3,909
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	27.76	37.26	36.00	36.90	54.27	81.36	136.02	262.05	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	8.33	9.32	7.24	6.06	5.81	6.09	6.33	5.63	4.81	4.74	4.34
Price to Earnings (P/E)	38.20	44.06	35.48	30.69	28.67	31.03	34.39	33.07	27.55	24.82	33.01
Dividend Yield	0.96%	0.87%	1.13%	1.37%	1.44%	1.32%	1.21%	1.31%	1.50%	1.58%	1.78%
Earnings Yield	2.62%	2.27%	2.82%	3.26%	3.49%	3.22%	2.91%	3.02%	3.63%	4.03%	3.03%
Enterprise Value to Invested Capital (EV/IC)	5.68	6.44	5.46	4.66	4.55	4.68	5.02	4.42	3.87	3.79	3.64
Enterprise Value to Revenue (EV/Rev)	9.74	10.74	8.61	7.51	7.31	7.65	7.84	7.25	6.55	6.56	6.17
Enterprise Value to EBITDA (EV/EBITDA)	23.33	25.99	20.96	18.60	18.43	19.55	20.44	19.32	17.22	16.94	20.50
Enterprise Value to EBIT (EV/EBIT)	31.48	35.40	28.93	26.09	26.18	28.14	29.75	28.66	24.37	22.77	28.81
Enterprise Value to NOPAT (EV/NOPAT)	35.72	40.26	32.98	29.07	26.96	28.37	30.49	29.67	26.90	25.17	30.71
Enterprise Value to Operating Cash Flow (EV/OCF)	26.20	29.08	24.23	21.31	21.04	23.19	22.52	21.09	20.27	20.06	25.85
Enterprise Value to Free Cash Flow (EV/FCFF)	144.55	77.82	52.20	39.44	34.55	42.75	48.05	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.58	6.23	7.50	9.40	14.23	20.28	31.31	58.15	-48.02	-24.08	-16.81
Long-Term Debt to Equity	5.10	5.65	6.68	8.25	13.34	18.84	29.72	55.54	-45.19	-21.50	-13.85
Financial Leverage	6.68	8.46	10.66	14.50	37.73	271.87	-60.28	-31.87	-13.64	-10.36	-18.81
Leverage Ratio	12.73	15.19	19.91	25.51	62.93	436.53	-102.37	-57.85	-23.73	-17.52	-38.49
Compound Leverage Factor	10.11	12.10	15.73	20.70	48.19	329.09	-74.88	-44.27	-16.84	-12.52	-26.09
Debt to Total Capital	84.80%	86.16%	88.24%	90.39%	93.43%	95.30%	96.90%	98.31%	102.13%	104.33%	106.33%
Short-Term Debt to Total Capital	7.19%	7.94%	9.61%	11.03%	5.85%	6.78%	4.90%	4.41%	6.02%	11.18%	18.69%
Long-Term Debt to Total Capital	77.60%	78.22%	78.63%	79.35%	87.58%	88.52%	92.00%	93.90%	96.10%	93.15%	87.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.47%	0.48%	0.47%	0.56%	0.59%	0.55%	0.51%	0.52%	0.57%	0.54%	0.49%
Common Equity to Total Capital	14.74%	13.36%	11.29%	9.06%	5.97%	4.15%	2.58%	1.17%	-2.69%	-4.87%	-6.82%
Debt to EBITDA	4.13	3.90	3.82	4.06	4.22	4.39	4.55	4.83	5.03	5.09	6.89
Net Debt to EBITDA	3.37	3.41	3.33	3.56	3.75	3.96	3.93	4.28	4.55	4.68	6.05
Long-Term Debt to EBITDA	3.78	3.54	3.41	3.56	3.96	4.08	4.32	4.61	4.73	4.55	5.68
Debt to NOPAT	6.33	6.05	6.01	6.35	6.18	6.38	6.78	7.42	7.86	7.57	10.32
Net Debt to NOPAT	5.16	5.28	5.24	5.57	5.48	5.75	5.86	6.58	7.11	6.96	9.05
Long-Term Debt to NOPAT	5.79	5.49	5.36	5.57	5.79	5.92	6.44	7.08	7.39	6.76	8.50
Altman Z-Score	2.22	2.53	1.94	1.65	1.59	1.61	1.60	1.44	1.13	1.00	0.79
Noncontrolling Interest Sharing Ratio	4.65%	5.38%	6.55%	9.43%	25.01%	163.12%	-34.39%	-22.20%	-9.82%	-6.80%	-12.72%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	0.81	0.72	0.72	0.85	0.79	0.87	0.91	0.82	0.65	0.60
Quick Ratio	0.87	0.67	0.59	0.59	0.69	0.63	0.73	0.74	0.65	0.50	0.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7,745	-3,150	-1,485	297	15	-1,351	-1,433	-29,242	-31,530	-31,364	-30,178
Operating Cash Flow to CapEx	101.21%	32.85%	322.49%	217.33%	327.06%	13.24%	530.75%	295.19%	162.67%	34.87%	371.96%
Free Cash Flow to Firm to Interest Expense	-8.68	-3.64	-1.76	0.34	0.02	-1.52	-1.64	-30.65	-34.73	-36.64	-38.35
Operating Cash Flow to Interest Expense	6.65	1.51	8.82	6.93	6.25	0.16	8.00	5.92	4.71	0.99	8.12
Operating Cash Flow Less CapEx to Interest Expense	0.08	-3.08	6.09	3.74	4.34	-1.06	6.49	3.91	1.81	-1.85	5.94
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.37	0.39	0.38	0.38	0.39	0.39	0.38	0.41	0.40	0.39	0.35
Accounts Receivable Turnover	7.27	7.33	7.40	7.16	7.77	7.94	8.18	7.76	8.88	8.64	8.48
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.18	2.47	2.64	2.74	2.96	3.19	3.41	3.73	3.84	4.12	4.44
Accounts Payable Turnover	5.65	5.87	6.59	5.80	6.10	6.92	7.39	6.98	5.91	5.52	6.07
Days Sales Outstanding (DSO)	50.21	49.77	49.31	50.96	46.95	45.96	44.61	47.01	41.10	42.22	43.06
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	64.65	62.19	55.39	62.99	59.81	52.76	49.40	52.26	61.80	66.13	60.11
Cash Conversion Cycle (CCC)	-14.44	-12.42	-6.08	-12.02	-12.85	-6.80	-4.80	-5.25	-20.69	-23.91	-17.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	95,714	91,549	84,873	85,447	84,258	84,477	79,699	81,850	81,130	79,793	74,908
Invested Capital Turnover	0.62	0.62	0.65	0.63	0.64	0.63	0.66	0.77	0.75	0.73	0.75
Increase / (Decrease) in Invested Capital	11,456	7,072	5,174	3,597	3,128	4,684	4,791	33,661	34,317	33,858	32,630
Enterprise Value (EV)	543,447	589,989	463,432	397,934	383,785	395,159	399,697	361,955	314,250	302,336	272,525
Market Capitalization	464,463	512,186	389,375	321,191	305,150	314,548	322,368	281,178	230,699	218,297	191,742
Book Value per Share	$5.98	$4.96	$3.92	$3.17	$2.05	$1.41	$0.87	$0.40	($0.90)	($1.58)	($2.20)
Tangible Book Value per Share	($18.08)	($19.54)	($20.94)	($21.98)	($23.36)	($24.36)	($25.39)	($26.31)	($27.68)	($28.70)	($30.02)
Total Capital	113,537	102,860	95,784	96,108	94,162	93,167	91,782	92,037	89,899	87,143	86,128
Total Debt	96,276	88,624	84,515	86,869	87,980	88,789	88,941	90,481	91,811	90,919	91,577
Total Long-Term Debt	88,109	80,462	75,314	76,264	82,470	82,468	84,442	86,420	86,396	81,173	75,480
Net Debt	78,453	77,313	73,604	76,208	78,076	80,099	76,858	80,294	83,042	83,569	80,357
Capital Expenditures (CapEx)	5,862	3,970	2,303	2,798	1,674	1,080	1,314	1,913	2,628	2,435	1,719
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9,163	-8,698	-10,683	-9,046	-8,216	-7,487	-10,775	-8,212	-7,538	-7,149	-8,938
Debt-free Net Working Capital (DFNWC)	8,660	2,613	228	1,615	1,688	1,203	1,308	1,975	1,231	201	2,282
Net Working Capital (NWC)	493	-5,549	-8,973	-8,990	-3,822	-5,118	-3,191	-2,086	-4,184	-9,545	-13,815
Net Nonoperating Expense (NNE)	775	771	760	751	742	830	938	1,101	891	753	904
Net Nonoperating Obligations (NNO)	78,453	77,313	73,604	76,208	78,076	80,099	76,858	80,294	83,042	83,569	80,357
Total Depreciation and Amortization (D&A)	1,551	1,499	1,428	1,554	1,557	1,553	1,475	1,586	1,558	1,498	1,466
Debt-free, Cash-free Net Working Capital to Revenue	-16.43%	-15.83%	-19.85%	-17.08%	-15.65%	-14.50%	-21.14%	-16.44%	-15.72%	-15.52%	-20.24%
Debt-free Net Working Capital to Revenue	15.52%	4.76%	0.42%	3.05%	3.21%	2.33%	2.57%	3.95%	2.57%	0.44%	5.17%
Net Working Capital to Revenue	0.88%	-10.10%	-16.67%	-16.97%	-7.28%	-9.91%	-6.26%	-4.18%	-8.72%	-20.72%	-31.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.05	$1.13	$1.06	$1.15	$0.87	$0.91	$0.89	$1.22	$0.70	$0.65	$0.58
Adjusted Weighted Average Basic Shares Outstanding	2.80B	2.79B	2.76B	2.74B	2.75B	2.75B	2.73B	2.70B	2.70B	2.70B	2.69B
Adjusted Diluted Earnings per Share	$1.02	$1.10	$1.03	$1.11	$0.85	$0.89	$0.86	$1.20	$0.68	$0.63	$0.56
Adjusted Weighted Average Diluted Shares Outstanding	2.87B	2.87B	2.85B	2.82B	2.82B	2.82B	2.82B	2.77B	2.78B	2.75B	2.75B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.80B	2.80B	2.77B	2.76B	2.75B	2.75B	2.74B	2.71B	2.70B	2.70B	2.70B
Normalized Net Operating Profit after Tax (NOPAT)	3,788	4,029	3,768	4,056	3,348	3,453	2,412	3,024	2,885	2,655	2,625
Normalized NOPAT Margin	26.81%	28.66%	28.32%	28.39%	25.21%	26.68%	19.36%	21.86%	23.27%	21.63%	22.93%
Pre Tax Income Margin	24.40%	24.11%	23.81%	26.46%	21.57%	21.02%	19.07%	22.46%	17.89%	17.47%	14.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.87	4.91	4.76	5.31	4.27	4.06	3.72	4.26	3.44	3.50	3.10
NOPAT to Interest Expense	4.16	4.53	4.38	4.44	3.59	3.75	3.85	4.63	3.07	2.91	3.12
EBIT Less CapEx to Interest Expense	-1.71	0.33	2.03	2.12	2.36	2.85	2.22	2.25	0.55	0.66	0.92
NOPAT Less CapEx to Interest Expense	-2.41	-0.05	1.65	1.25	1.68	2.54	2.34	2.63	0.17	0.07	0.93
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	36.53%	38.04%	40.11%	41.95%	41.07%	40.79%	41.59%	43.14%	41.08%	39.02%	59.06%
Augmented Payout Ratio	41.48%	45.80%	51.07%	53.43%	52.35%	49.67%	51.17%	58.43%	61.91%	64.56%	210.66%

Frequently Asked Questions About Oracle's Financials

When does Oracle's fiscal year end?

According to the most recent income statement we have on file, Oracle's financial year ends in May. Their financial year 2024 ended on May 31, 2024.

How has Oracle's net income changed over the last 9 years?

Oracle's net income were at $10.47 billion at the end of 2024, a 23.1% increase from 2023, and a 5.3% increase since 2015. View Oracle's forecast to see where analysts expect Oracle to go next.

What is Oracle's operating income?

Oracle's total operating income in 2024 was $15.35 billion, based on the following breakdown:

Total Gross Profit: $42.64 billion
Total Operating Expenses: $27.29 billion

How has Oracle revenue changed over the last 9 years?

Over the last 9 years, Oracle's total revenue changed from $38.23 billion in 2015 to $52.96 billion in 2024, a change of 38.5%.

How much debt does Oracle have?

Oracle's total liabilities were at $131.74 billion at the end of 2024, a 0.8% decrease from 2023, and a 113.1% increase since 2015.

How much cash does Oracle have?

In the past 9 years, Oracle's cash and equivalents has ranged from $9.77 billion in 2023 to $37.24 billion in 2020, and is currently $10.45 billion as of their latest financial filing in 2024.

How has Oracle's book value per share changed over the last 9 years?

Over the last 9 years, Oracle's book value per share changed from 11.14 in 2015 to 3.17 in 2024, a change of -71.6%.

Related Companies

This page (NYSE:ORCL) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Financials

Frequently Asked Questions About Oracle's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Oracle (ORCL) Financials

Annual Income Statements for Oracle

Quarterly Income Statements for Oracle

Annual Cash Flow Statements for Oracle

Quarterly Cash Flow Statements for Oracle

Annual Balance Sheets for Oracle

Quarterly Balance Sheets for Oracle

Annual Metrics And Ratios for Oracle

Quarterly Metrics And Ratios for Oracle

Frequently Asked Questions About Oracle's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools